Literature DB >> 12514972

Change in distribution & antifungal susceptibility of Candida species isolated from candidaemia cases in a tertiary care centre during 1996-2000.

A Chakrabarti1, B Mohan, S K Shrivastava, R S K Marak, A Ghosh, P Ray.   

Abstract

BACKGROUND &
OBJECTIVES: As a marked increase in the number of patients with candidaemia was reported in the first half (1991-1995) of the last decade at the Postgraduate Institute of Medical Education & Research, Chandigarh, India, the present study was aimed at determining further change if any, in the incidence and distribution of Candida species and their antifungal resistance pattern during the second half (1996-2000) of the same decade.
METHODS: The patients with candidaemia were studied to determine the frequency of candidaemia and Candida species isolated during 1996-2000. One hundred Candida strains other than Pichia anomala (C. pelliculosa) were randomly selected from those isolates to evaluate antifungal susceptibility pattern against amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. The results were compared with our previous study.
RESULTS: An increase in the number of patients with candidaemia was observed during 1996 (538) and 1997 (421) compared to 1998-2000 due to P. anomala outbreak. With the control of the outbreak, a substantial decrease in the incidence of candidaemia was observed from 1998 (251 in 1998, 122 in 1999 and 165 in 2000). A higher isolation of non-C. albicans Candida species (89.8%) was observed, with C. tropicalis being the most common (541, 36.1%) agent. No major change in the isolation rate of other non-C. albicans Candida species (C. guilliermondii, C. krusei, C. glabrata and C. parapsilosis) was observed. An emergence of resistance to amphotericin B in 15.4 per cent C. albicans, 8.1 per cent C. tropicalis and 33.3 per cent C. krusei strains was observed. An increase in resistance to ketoconazole (from 0% to 13%) and 5-fluorocytosine (from 1% to 8%) and a decrease to fluconazole (from 13% to 6%) were observed. Resistance to itraconazole was observed in 17 per cent of Candida strains by broth macro-dilution method. INTERPRETATION &
CONCLUSION: A change in the isolation of Candida species was observed i.e. in the incidence and isolation of non-C. albicans Candida species. Emergence of resistance to amphotericin B and increase of resistance to most other antifungals are cause for concern.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12514972

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  7 in total

1.  Pattern of Candida isolates in hospitalized children.

Authors:  Rumpa Saha; Shukla Das Das; Ashwani Kumar; Iqbal R Kaur
Journal:  Indian J Pediatr       Date:  2008-09-04       Impact factor: 1.967

2.  Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of mangalore.

Authors:  Yashavanth R; Shiju M P; Bhaskar U A; Ronald R; Anita K B
Journal:  J Clin Diagn Res       Date:  2013-11-10

3.  Nosocomial bloodstream infection in a pediatric intensive care unit.

Authors:  Sunit Singhi; Pallab Ray; Joseph L Mathew; M Jayashree
Journal:  Indian J Pediatr       Date:  2008-01       Impact factor: 1.967

4.  Candida in acute pancreatitis.

Authors:  Arunaloke Chakrabarti; Pooja Rao; Bansidhar Tarai; Mandya Rudramurthy Shivaprakash; Jaidev Wig
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

5.  Fungal infections in intensive care unit: challenges in diagnosis and management.

Authors:  Sj Bajwa; A Kulshrestha
Journal:  Ann Med Health Sci Res       Date:  2013-04

6.  The epidemiological profile of candidemia at an Indian trauma care center.

Authors:  Vibhor Tak; Purva Mathur; Prince Varghese; Jacinta Gunjiyal; Immaculata Xess; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2014-07

7.  Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India.

Authors:  P Bhattacharjee
Journal:  Curr Med Mycol       Date:  2016-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.